Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
There is no Therapeutic Use Exemption pathway because BPC-157 has no approved therapeutic indication in any major jurisdiction
Dumaswala et al
Speak to a medical professional about using BPC-157
FDA in 2010 for reducing excess visceral adipose tissue (VAT), the deep abdominal fat around the organs, in adults with HIV-associated lipodystrophy
Olivia E
Users of Brand-Name GLP-1s Report Slightly Lower Effectiveness Users of brand-name GLP-1 medications report slightly lower effectiveness than do users of compounded or custom-mixed versions, but both types of patients consider the drugs to be effective
US$ 23.72
US$ 20.12
US$ 21.52
US$ 24.86
US$ 24.57
US$ 28.23
